News

Pennsaid Topical Solution is a non-steroidal anti-inflammatory drug used for the treatment of the signs and symptoms of osteoarthritis of the knee. Dan Chicoine, chairman of Nuvo Research,

Catalent Pharma Solutions (Catalent) has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides. Using Catalent’s drug delivery technologies, the

Aureus Pharma has extended its knowledge database agreement with sanofi-aventis research & development for an additional three-year term. Under the agreement, Aureus will provide new AurSCOPE knowledge databases

This four-year contract has a total value of over $22m if all options are exercised. Over the next year, GenVec will receive approximately $2.6m. Under the contract, the

It covers a method of treating insomnia by administering zolpidem to humans utilising NovaMist oral spray. NovaDel’s Zolpimist (zolpidem tartrate) 5 mg and 10 mg oral spray product

The FDA has approved Gloucester Pharmaceuticals’ Istodax (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL), in patients who have received at least one prior systemic therapy. Istodax

Novartis has received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza A(H1N1) 2009 monovalent vaccine, Celtura. Novartis said that it will continue to pursue

Bayer Consumer Care (BCC) has launched Citracal Calcium Plus Heart Health, a calcium supplement to help support bone and heart health. Bayer claimed that the new supplement addresses

Theravance and Astellas Pharma have commercially launched Vibativ (telavancin) in the US. FDA approved Vibativ for the treatment of adult patients with complicated skin and skin structure infections